The sale was led by ABL Corporate and M&A Partner Michael Dodge, with support from Lawyer Emily Ellis-Czerkaski.
The agreement allows Pure Beauty, an up and coming player in the cosmetic industry, to market the existing BioElixia® range and expand with new products containing Phosphagenics’ TPM® technology.
Phosphagenics is an biotechnology company focused on developing and commercialising innovative human health, animal health and personal care products using its proprietary drug delivery system called TPM® (Targeted Penetration Matrix).
Ross Murdoch, Chief Executive Officer of Phosphagenics commented: “This is a tremendous endorsement for our TPM® technology and I believe this arrangement will at last allow Phosphagenics shareholders to see BioElixia® reach its potential.”
The ABL team advised on all legal aspects of the transaction, including the terms of the sale, the licensing of the intellectual property and the supply of TPM®.
ABL Partner Michael Dodge added: “We are pleased to support Phosphagenics in this important transaction. It has been a strategic objective of Phosphagenics for some time to revitalise the BioElixia brand in a manner that is designed to deliver long term benefits to Phosphagenics. We are pleased to have assisted Phosphagenics to achieve this key goal and we look forward to watching the brand’s future success.”
For more information, or to arrange an interview, contact Aleks Czerwinski, Marketing & Business Development Manager, email@example.com or (+613) 9229 9715.
About Arnold Bloch Leibler
Arnold Bloch Leibler is a premium Australian commercial law firm renowned for advising on clients on their most important transactions, commercial issues and disputes. From offices in Melbourne and Sydney, the firm provides advice to a diverse range of entrepreneurial Australian listed companies, family businesses, high-net-worth individuals and international corporations. The firm also has a dedicated pro bono practice providing advice on social, environmental and cultural issues to more than 150 charitable and not-for-profit organisations.